Research involving meningioma continues. The following advancements may still be under investigation in clinical trials and may not be approved or available at this current time. Always discuss all diagnostic and treatment options with your doctor. The following meningioma developments are being explored:
Hyperfractionization uses smaller doses of radiation therapy at more frequent intervals.
Gene therapy seeks to correct faulty genes that are causing tumor growth.
Hormonal drugs are being investigated because research has shown a possible link between meningioma and hormone levels.
Immunotherapy boosts the body’s natural defenses to attack the tumor. It uses natural materials either made by the body or in a laboratory to bolster, target, or restore immune system function.
Antiangiogenesis therapy is the use of drugs to stop tumors from developing new blood vessels. Without blood vessels feeding the tumor with blood, the tumor cannot grow.
Drugs affecting other intracellular functions are also being tested, including drugs that affect molecules that control cell division through signal transduction pathways.
Last Updated: October 30, 2009
